Jury Rejects Feds' Claims Gilead Infringed HIV Drug Patents
A six-member federal jury in Delaware rejected a potential billion-dollar government claim Tuesday that Gilead Sciences Inc. infringed government-owned patents when it fielded its Truvada and Descovy drugs to treat or...To view the full article, register now.
Already a subscriber? Click here to view full article